Table III.
Types of surgery and specialties involved.
| Surgery | Total (n = 657) | Group C: COVID-19 (n = 39) | Group D: non-COVID-19 (n = 618) | p-value |
|---|---|---|---|---|
| Orthopaedic procedures, n (%) | ||||
| ORIF | 99 (15.1) | 4 (10.3) | 95 (15.4) | 0.493 |
| Hemi | 20 (3.0) | 4 (10.3) | 16 (2.6) | 0.026‡ |
| DHS | 15 (2.3) | 1 (2.6) | 14 (2.3) | 0.605‡ |
| Intramedullary nail | 31 (4.7) | 2 (5.1) | 29 (4.7) | 0.705‡ |
| Exploration | 17 (2.6) | 0 (0.0) | 17 (2.8) | 0.616‡ |
| Debridement & washout | 31 (4.7) | 2 (5.1) | 29 (4.7) | 0.705‡ |
| MUA | 2 (0.3) | 0 (0.0) | 2 (0.3) | 1.000‡ |
| Ex-fix | 5 (0.8) | 0 (0.0) | 5 (0.8) | 1.000‡ |
| Tendon repair | 9 (1.4) | 0 (0.0) | 9 (1.5) | 1.000‡ |
| Arthroscopy | 4 (0.6) | 0 (0.0) | 4 (0.6) | 1.000‡ |
| Total | 233 (35.4) | 13 (33.3) | 220 (35.6) | 1.000‡ |
| Specialities involved, n (%) | ||||
| Plastics | 24 (3.7) | 0 (0.0) | 24 (3.9) | 0.389‡ |
| Cardiothoracic | 55 (8.4) | 5 (12.8) | 50 (8.1) | 0.363‡ |
| Neurosurgery/spine | 129 (19.6) | 12 (30.8) | 117 (18.9) | 0.094‡ |
| General surgery | 41 (6.2) | 2 (5.1) | 39 (6.3) | 1.000‡ |
| Maxillofacial | 19 (2.9) | 2 (5.1) | 17 (2.8) | 0.313‡ |
| ENT | 4 (0.6) | 0 (0.0) | 4 (0.6) | 1.000‡ |
| ICU admissions | 31 (4.7) | 2 (5.1) | 29 (4.7) | 0.693‡ |
| Mortality | 31 (4.7) | 8 (20.5) | 23 (3.7) | < 0.000‡ |
*
The test statistics are for the null hypothesis significance test for thecomparison of the COVID patients with non-COVID patients. ‡Fisher’s Exact test conducted due to invalid Chi-Squared test. Statistically significant.
ORIF, open reduction internal fixation; DHS, dynamic hip screw; MUA, manipulation under anaesthesia; ENT, ear, nose, throat; ICU, intensive care unit.